Getty Images

Alex Colome’s Players Weekend Jersey is . . . interesting

19 Comments

As we noted yesterday, as part of “Players Weekend” on August 25-27, teams will wear bright, pullover alternative jerseys which, if they so choose, will feature nicknames on their backs. Some of the nicknames are pretty good. Some are lame. Some players chose not to pick a nicknames which, per Geddy Lee, means they still made a choice. A boring one, but it’s a free country.

One player, however, chose a pretty interesting nickname. That player is Alex Colome, the closer for the Tampa Bay Rays. This is what he chose:

Good name for a pitcher, right? You want to be the horse your team can ride when it needs to! But I also wonder if there is something else going on.

You may or may not recall that back in 2014 Colome was suspended for PEDs. The drug he took: Boldenone. Here’s what Boldenone, which a lot of athletes have abused in the past, was actually developed for:

Equipoise (Boldenone Undecylenate Injection) is a long-acting injectable anabolic agent for horses, supplied in a vial providing 50 mg boldenone undecylenate per mL in sesame oil with 3% (w/v) benzyl alcohol as a preservative.

Yep: “anabolic agent for horses.”

The best nicknames are earned, not merely given. And self-effacing humor is one of the more attractive traits an otherwise confident person can have. As such: well played, Alex.

Rangers will not exercise Mike Napoli’s 2018 option

Rick Yeatts/Getty Images
Leave a comment

The Rangers have informed 1B/DH Mike Napoli the club will not exercise his 2018 option, worth $11 million, Evan Grant of the Dallas Morning News reports. Instead, the Rangers will pay Napoli $2.5 million to buy him out of his contract, making him a free agent.

Napoli, 35, hit a disappointing .193/.285/.428 with 29 home runs and 66 RBI in 485 plate appearances this past season. Given his age and declining production, it’s not shocking that the Rangers want to look elsewhere.

Napoli turns 36 at the end of the month. Given his age and worsening peripheral stats, he will likely have to settle for a one-year deal this offseason.